{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:16:10Z","timestamp":1792815370768,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:00Z","timestamp":1792800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:00Z","timestamp":1792800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fudan University Clinical Research Management Soft Science Project","award":["CRMP2025-19"],"award-info":[{"award-number":["CRMP2025-19"]}],"id":[{"id":"https:\/\/ror.org\/05k7cyf48","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Clinical Research Special Project of Zhongshan Hospital, Fudan University","award":["ZSLCYJZX202561"],"award-info":[{"award-number":["ZSLCYJZX202561"]}],"id":[{"id":"https:\/\/ror.org\/013q1eq08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00520-026-11374-7","type":"journal-article","created":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:06:26Z","timestamp":1792807586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world nausea\/vomiting control during anticancer therapy: a cross-sectional survey"],"prefix":"10.1007","volume":"34","author":[{"given":"Wanqiu","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changding","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,24]]},"reference":[{"issue":"2","key":"11374_CR1","doi-asserted-by":"publisher","first-page":"102195","DOI":"10.1016\/j.esmoop.2023.102195","volume":"9","author":"J Herrstedt","year":"2024","unstructured":"Herrstedt J, Clark-Snow R, Ruhlmann CH, Molassiotis A, Olver I, Rapoport BL et al (2024) 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. ESMO Open 9(2):102195. https:\/\/doi.org\/10.1016\/j.esmoop.2023.102195","journal-title":"ESMO Open"},{"issue":"24","key":"11374_CR2","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1200\/JCO.20.01296","volume":"38","author":"PJ Hesketh","year":"2020","unstructured":"Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA et al (2020) Antiemetics: ASCO guideline update. J Clin Oncol 38(24):2782\u20132797. https:\/\/doi.org\/10.1200\/JCO.20.01296","journal-title":"J Clin Oncol"},{"key":"11374_CR3","unstructured":"National Comprehensive Cancer Network (2023) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Antiemesis, Version 2.2023. National Comprehensive Cancer Network, Plymouth Meeting, PA"},{"issue":"1","key":"11374_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08221-4","volume":"32","author":"J Herrstedt","year":"2024","unstructured":"Herrstedt J, Celio L, Hesketh PJ, Zhang L, Navari RM, Chan A et al (2024) 2023 updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Support Care Cancer 32(1):47. https:\/\/doi.org\/10.1007\/s00520-023-08221-4","journal-title":"Support Care Cancer"},{"issue":"1","key":"11374_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00520-023-08222-3","volume":"32","author":"F Scott\u00e9","year":"2024","unstructured":"Scott\u00e9 F, Schwartzberg L, Iihara H, Aapro M, Gralla R, Hesketh PJ et al (2024) 2023 updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Support Care Cancer 32(1):45. https:\/\/doi.org\/10.1007\/s00520-023-08222-3","journal-title":"Support Care Cancer"},{"key":"11374_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00520-026-10460-0","volume":"34","author":"R Caponero","year":"2026","unstructured":"Caponero R, Enrico D, Giudice F, Ayoub JP, Lapointe N (2026) Awareness of chemotherapy-induced nausea and vomiting and adherence to guidelines: results of a multinational and multicenter survey, part of the THRIVE program. Support Care Cancer 34:334. https:\/\/doi.org\/10.1007\/s00520-026-10460-0","journal-title":"Support Care Cancer"},{"key":"11374_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2022.01.028","volume":"166","author":"M Aapro","year":"2022","unstructured":"Aapro M, Caprariu Z, Chilingirov P, Chr\u00e1pav\u00e1 M, Curca RO, Gales L et al (2022) Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: results of the nausea\/emesis registry in oncology (NERO). Eur J Cancer 166:126\u2013133. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.028","journal-title":"Eur J Cancer"},{"issue":"6","key":"11374_CR8","doi-asserted-by":"publisher","first-page":"e1073","DOI":"10.1002\/onco.13716","volume":"26","author":"M Aapro","year":"2021","unstructured":"Aapro M, Scott\u00e9 F, Escobar Y, Celio L, Berman R, Franceschetti A et al (2021) Practice patterns for prevention of chemotherapy-induced nausea and vomiting and antiemetic guideline adherence based on real-world prescribing data. Oncologist 26(6):e1073\u2013e1082. https:\/\/doi.org\/10.1002\/onco.13716","journal-title":"Oncologist"},{"issue":"6","key":"11374_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.6004\/jnccn.2019.7526","volume":"18","author":"EJ Roeland","year":"2020","unstructured":"Roeland EJ, Ruddy KJ, LeBlanc TW, Nipp RD, Binder G, Sebastiani S et al (2020) What the HEC? Clinician adherence to evidence-based antiemetic prophylaxis for highly emetogenic chemotherapy. J Natl Compr Canc Netw 18(6):676\u2013681. https:\/\/doi.org\/10.6004\/jnccn.2019.7526","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"11374_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JOP.2012.000816","volume":"10","author":"JW Gilmore","year":"2014","unstructured":"Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharpe J et al (2014) Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE study. J Oncol Pract 10(1):68\u201374. https:\/\/doi.org\/10.1200\/JOP.2012.000816","journal-title":"J Oncol Pract"},{"issue":"8","key":"11374_CR11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","volume":"33","author":"M Di Maio","year":"2015","unstructured":"Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F et al (2015) Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol 33(8):910\u2013915. https:\/\/doi.org\/10.1200\/JCO.2014.57.9334","journal-title":"J Clin Oncol"},{"key":"11374_CR12","doi-asserted-by":"publisher","first-page":"102512","DOI":"10.1016\/j.ctrv.2023.102512","volume":"115","author":"M Filetti","year":"2023","unstructured":"Filetti M, Lombardi P, Giusti R, Falcone R, Scott\u00e9 F, Giannarelli D et al (2023) Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: a systematic review and network meta-analysis. Cancer Treat Rev 115:102512. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102512","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"11374_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1470-2045(19)30678-3","volume":"21","author":"H Hashimoto","year":"2020","unstructured":"Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T et al (2020) Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 21(2):242\u2013249. https:\/\/doi.org\/10.1016\/S1470-2045(19)30678-3","journal-title":"Lancet Oncol"},{"key":"11374_CR14","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.eclinm.2022.101771","volume":"55","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Yang Y, Gao F, Hu C, Zhong D, Lu M et al (2023) A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study). EClinicalMedicine 55:101771. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101771","journal-title":"EClinicalMedicine"},{"issue":"23","key":"11374_CR15","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.24.00278","volume":"42","author":"N Inui","year":"2024","unstructured":"Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Mori K et al (2024) Olanzapine plus triple antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting: a randomized, double-blind, placebo-controlled phase III trial. J Clin Oncol 42(23):2780\u20132789. https:\/\/doi.org\/10.1200\/JCO.24.00278","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11374-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11374-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11374-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:06:27Z","timestamp":1792807587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11374-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,24]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11374"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11374-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,24]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study used anonymized physician-completed questionnaire records, involved no direct patient contact or intervention, did not alter diagnosis or treatment, collected no identifiable personal information or biological samples, and posed no more than minimal risk. It therefore met criteria for exemption from formal ethics review.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1151"}}